antimony has been researched along with Ovarian Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bush, RS; Dembo, AJ; Ege, GN | 1 |
| DeCosse, JJ; Meijer, WS; Osborne, MP; Yeh, SD | 1 |
| Enns, RE; Heath, DD; Howell, SB; Naredi, P | 1 |
1 review(s) available for antimony and Ovarian Neoplasms
| Article | Year |
|---|---|
Lymphoscintigraphy in the staging of solid tumors.
Topics: Antimony; Ascites; Breast Neoplasms; Colloids; Female; Gastrointestinal Neoplasms; Gold Colloid, Radioactive; Humans; Indium; Lung Neoplasms; Lymphoscintigraphy; Male; Melanoma; Mercury Radioisotopes; Methods; Neoplasm Staging; Organotechnetium Compounds; Ovarian Neoplasms; Phytic Acid; Prostatic Neoplasms; Radioisotopes; Sulfur; Technetium; Technetium Compounds; Technetium Tc 99m Sulfur Colloid | 1983 |
2 other study(ies) available for antimony and Ovarian Neoplasms
| Article | Year |
|---|---|
Internal mammary lymphoscintigraphy in the assessment of patients with ovarian carcinoma.
Topics: Adenocarcinoma, Mucinous; Antimony; Breast; Evaluation Studies as Topic; Female; Humans; Lymph Nodes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Radionuclide Imaging; Technetium; Technetium Compounds | 1982 |
Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line.
Topics: Antimony; Antimony Potassium Tartrate; Cadmium; Cisplatin; Cobalt; Cystadenocarcinoma, Serous; Drug Resistance; Drug Screening Assays, Antitumor; Female; Glutathione; Humans; Nickel; Ovarian Neoplasms; Tumor Cells, Cultured; Zinc | 1994 |